Karyotypes found in the population declared at increased risk of Down syndrome following maternal serum screening
- 3 July 2001
- journal article
- Published by Wiley in Prenatal Diagnosis
- Vol. 21 (7) , 553-557
- https://doi.org/10.1002/pd.108
Abstract
Of the 65 328 pregnancies of South Australian mothers screened by the South Australian Maternal Serum Antenatal Screening (SAMSAS) Programme between 1 January 1991 and 31 December 1997, 3431 (5.25%) were declared at increased risk of fetal Down syndrome. Fetal or neonatal karyotype was determined in 2737/3431 (79.8%) of these pregnancies, including 16 with early fetal loss. Interrogation of the database of the South Australian Neonatal Screening Service showed 643 live‐born infants whose phenotype was not subsequently questioned among the 694 pregnancies whose karyotype was not determined. Of the remaining 51/3431 pregnancies, 19 ended in early fetal loss without karyotyping and no newborn screening or other records could be found for 32 cases. The 129 instances of abnormal karyotype found were Down syndrome (84), trisomy 18 (four), trisomy 13 (three), triploidy (two), female sex chromosome aneuploidy (six) and male sex chromosome aneuploidy (five), inherited balanced rearrangements (19), mosaic or de novo balanced abnormalities (four) and unbalanced karyotypes (two). In the pregnancies declared at increased risk of fetal Down syndrome, only the karyotype for Down syndrome occurred with a frequency greater than that expected for the general, pregnant population. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 17 references indexed in Scilit:
- Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk, Result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian populationActa Obstetricia et Gynecologica Scandinavica, 1999
- Elevated Second-Trimester Maternal Urine Free Beta-Human Chorionic Gonadotropin Levels in Asian Pregnancies with Fetal Chromosomal AbnormalitiesFetal Diagnosis and Therapy, 1998
- Counselling implications of chromosomal abnormalities other than trisomy 21 detected through a maternal serum screening programmeBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndromeAmerican Journal of Obstetrics and Gynecology, 1995
- Fluorescent in situ Hybridization and Second-Trimester Sonographic Anomalies: Uses and LimitationsFetal Diagnosis and Therapy, 1994
- Low maternal serum levels of pregnancy associated plasma protein A (PAPP‐A) in the first trimester in association with abnormal fetal karyotypeBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Improved performance in a prenatal screening programme for Down's syndrome incorporating serum‐free hCG subunit analysesPrenatal Diagnosis, 1992
- Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative european study on 52 965 amniocentesesPrenatal Diagnosis, 1984